U.S. stock night trading opens with fluctuations: Amber rises 6.88% in night trading; Boqii rises 6.58% in night trading

U.S. Stock Night Market Opening Movements

Amber rose 6.88% in the night market. Based on recent news,

1. On November 26, Amber International Holding announced better-than-expected third-quarter sales results and a $50 million stock repurchase plan. The company's third-quarter revenue was $16.3 million, a year-on-year increase of 1934.6%, with a net profit of $2.15 million. This news boosted market confidence and drove the stock price up.

2. On November 26, the board of directors of Amber International Holding approved a 12-month stock repurchase plan, with a maximum repurchase amount of $50 million. The plan aims to repurchase shares using cash reserves and cash generated from operations, further enhancing investor confidence in the company's future development.

3. On November 26, Amber International Holding announced that its client assets increased by 69.8% year-on-year, reaching $1.842 billion, and launched a new physical asset platform to meet institutional demand. This series of positive financial and strategic initiatives drove the stock price up. The digital wealth management industry is performing strongly, with AI technology integration enhancing efficiency.

Boqii rose 6.58% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Top Gainers in the U.S. Stock Night Market

HeartBeam rose 44.77% in the night market. Based on recent key news:

1. On November 26, HeartBeam updated the regulatory pathway for its 12-lead electrocardiogram synthesis software application. This update is based on the FDA's decision and may have significant implications for the company's future product development and market strategy, driving the stock price up.

2. On November 26, HeartBeam released usage instructions for its portable non-invasive electrocardiogram recorder. This device is designed to record, store, and transmit patients' three-lead electrocardiograms, suitable for clinical or home environments. The market potential of this product is viewed positively by investors, further stimulating the stock price rise.

3. On November 26, HeartBeam published original content via Business Wire, emphasizing its responsibility for forward-looking statements. This statement may enhance market confidence in the company's transparency and future development, boosting the stock price. The medical device industry has performed strongly recently, with significant capital inflows.

TScan Therapeutics rose 20.72% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

TMC the Metals rose 20.07% in the night market. Based on recent news,

1. On November 27th, TMC The Metals Company may solve the global metal shortage problem. If its solution receives regulatory approval, the stock will rise significantly.

2. On November 25th, despite the company's ambitions in deep-sea mining, success is not guaranteed. Only investors with a high-risk tolerance should consider investing in TMC.

3. On November 28th, analysts rated TMC as a hold, believing there are five other stocks that are more worthy of investment. Washington's interest in critical mineral supplies is increasing